Clinical trial

Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Vitreous Hemorrhage

NCT01091896

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2010-01-01

PhasePHASE2

Study timeline

Study start (unknown)2010-01-01Date precision: month

Registry last updated2010-03-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Vitreous Hemorrhage Secondary to PDRunresolved

Interventions

BevacizumabDRUG · verified · RxNorm: bevacizumab

bevacizumabDRUG · verified · RxNorm: bevacizumab

Sponsors & collaborators

University of Sao Paulolead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01091896 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.